溶解物载体SLC7A1可能在血脑屏障中充当蛋白质载体
Magdalena Kurtyka1, Frank Wessely2, Sarah Bau3
1Institute for Pathobiochemistry, University Medical Center Mainz, Mainz, Germany.
European journal of cell biology
|March 28, 2024
概括
研究人员确定了高亲和度氨基酸载体1 (SLC7A1) 作为一种新的目标,用于将大分子通过血脑屏障 (BBB). 这一发现为大脑药物输送提供了一条新的途径.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- 针对性地向中枢神经系统 (CNS) 输送药物是具有挑战性的,因为血脑屏障 (BBB).
- 对于中枢神经系统的进入,现有的运输系统是有限的,特别是对于大分子.
- 识别新的BBB目标对于推进脑疗法至关重要.
研究的目的:
- 为了确定新的,大脑内皮质丰富的目标,用于跨越BBB运输大分子.
- 为了研究高亲和度氨基酸载体1 (SLC7A1) 作为BBB运输目标的潜力.
主要方法:
- 对人类和小鼠大脑内皮的转录分析.
- 对富含BBB的基因进行查.
- RNA测序和现场杂交以确认SLC7A1的表达.
- 使用抗SLC7A1抗体进行体外内化和转细胞检测.
主要成果:
- 确定SLC7A1是跨越BBB的新型候选载体.
- 在人类和小鼠大脑内皮中证实SLC7A1基因和蛋白质表达的升高.
- SLC7A1有效地将特定的抗体内部化并通过内皮细胞运输.
结论:
- SLC7A1代表了一种有前途的新型目标,用于在BBB中运输大型分子,包括抗体.
- 这一发现为开发针对中枢神经系统疾病的向疗法开辟了新的途径.
关键词:
这是BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB在CAT-1中,它是CAT-1.在SLC7A1A1中.大脑药物输送大脑药物输送大脑治疗学 脑疗法溶液载体是溶解物质的载体相关概念视频
Transcellular Transport of Solutes
3.6K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.6K
The Blood-brain Barrier
47.3K
Overview
47.3K
Membrane Transporters
10.9K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
10.9K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
The Significance of Membrane Transport
25.7K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
25.7K
Carrier-Mediated Transport
415
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
415


